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ARTICLE
SYK kinase mediates brown fat differentiation and
activation
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Brown adipose tissue (BAT) metabolism inﬂuences glucose homeostasis and metabolic
health in mice and humans. Sympathetic stimulation of β-adrenergic receptors in response to
cold induces proliferation, differentiation, and UCP1 expression in pre-adipocytes and mature
brown adipocytes. Here we show that spleen tyrosine kinase (SYK) is upregulated during
brown adipocyte differentiation and activated by β-adrenergic stimulation. Deletion or inhi-
bition of SYK, a kinase known for its essential roles in the immune system, blocks brown and
white pre-adipocyte proliferation and differentiation in vitro, and results in diminished
expression of Ucp1 and other genes regulating brown adipocyte function in response to β-
adrenergic stimulation. Adipocyte-speciﬁc SYK deletion in mice reduces BAT mass and BAT
that developed consisted of SYK-expressing brown adipocytes that had escaped homozygous
Syk deletion. SYK inhibition in vivo represses β-agonist-induced thermogenesis and oxygen
consumption. These results establish SYK as an essential mediator of brown fat formation
and function.
DOI: 10.1038/s41467-017-02162-3 OPEN
1Whitehead Institute for Biomedical Research, 455 Main Street, Cambridge, MA 02142, USA. 2Department of Biology, University of Copenhagen,
Universitetsparken 13, DK-2100 Copenhagen, Denmark. 3 Department of Pathology, Brigham and Women’s Hospital, 75 Francis Street, Boston, MA 02115,
USA. 4Department of Medicine, University of Wisconsin-Madison, 1685 Highland Avenue, Madison, WI 53705, USA. 5 Cardiovascular and Metabolic
Disorders, Duke-NUS Graduate Medical School, 8 College Road, Singapore 169857, Singapore. 6 Departments of Biology and Biological Engineering,
Massachusetts Institute of Technology, 21 Ames Street, Cambridge, MA 02142, USA. Marko Knoll and Sally Winther contributed equally to this work.
Correspondence and requests for materials should be addressed to H.F.L. (email: lodish@wi.mit.edu)
NATURE COMMUNICATIONS |8:  2115 |DOI: 10.1038/s41467-017-02162-3 |www.nature.com/naturecommunications 1
12
34
56
78
9
0
Adipose tissue is an essential regulator of energy balanceand nutritional homeostasis1. Of the two principal typesof adipose tissue, white adipose tissue (WAT) is specia-
lized to store chemical energy in the form of triglycerides. On the
other hand, brown adipose tissue (BAT), is specialized to generate
heat and consume energy as a defense against cold; BAT protects
from excessive weight gain in response to overfeeding1, 2. Cold
exposure, through β-adrenergic signaling, induces changes in
both tissues. In BAT, cold exposure increases Ucp1 expression,
mitochondrial biogenesis, and tissue expansion, resulting in an
increase of thermogenic capacity2. In WAT, cold exposure leads
to the emergence of beige, or inducible brown, adipocytes3.
Brown adipocyte differentiation and activation in response to
β-adrenergic stimulation can be modeled in vitro by inducing
ex vivo isolated brown adipocyte precursors or precursor cell lines
to assume a brown adipocyte-like phenotype, followed by sti-
mulation with β-adrenergic agonists such as isoproterenol4–6. β-
adrenergic stimulation, by cold or pharmacological agents, initi-
ates numerous processes in the brown adipocytes aimed at
increasing thermogenic activity and tissue recruitment. Rapid
effects include increased nutrient uptake, lipolytic activation, and
activation of UCP1. Prolonged β-adrenergic stimulation induces
proliferation and differentiation of brown adipocyte precursor
cells, mitochondrial biogenesis, as well as changes in gene
expression and browning of WAT to increase thermogenic
capacity7, 8.
Spleen tyrosine kinase (SYK) is critical for survival, differ-
entiation, and activation of several types of hematopoietic cells9.
Recruitment of its paired SH2 domains to dually phosphorylated
tyrosine binding motifs, termed immunoreceptor tyrosine based
activation motifs (ITAMs), localizes SYK to ITAM linked
receptors such as the B cell receptor (BCR) and activation of SYK
is also mediated by Src-family tyrosine kinases such as Lck/Yes
novel tyrosine kinase (LYN). Thus, SYK connects the BCR and
other immune receptors with downstream activation of numer-
ous pathways resulting in calcium release and transcriptional
responses9.
Although initially characterized as a hematopoietic cell-speciﬁc
kinase essential for immune receptor signaling, SYK has been
ascribed functions in other signaling cascades not only in
immune cells but also in cells such as ﬁbroblasts and endothelial
cells10.
Using a kinase inhibitor library, we show here that SYK is
required for β-adrenergic stimulated upregulation of Ucp1 in
mature brown adipocytes. We utilized numerous inhibitors, gene
knock downs, and gene knockout strategies to show that SYK
regulates activation, proliferation, and differentiation of brown
adipocytes. In vivo, knockout of SYK is incompatible with brown
adipose formation, and we observed a strong counter selection for
SYK proﬁcient cells. SYK inhibition in established BAT in vivo
inhibited β-agonist-induced thermogenesis and oxygen con-
sumption. These results establish SYK as an essential mediator of
brown fat formation and function, and suggest that pharmaco-
logical modulation of SYK activity could have an impact on
certain metabolic diseases.
Results
SYK is expressed in BAT and induced during brown adipo-
genesis. In order to identify kinases required for isoproterenol-
induced Ucp1 expression in brown adipocytes, we pretreated
mature immortalized brown adipocytes on day 8 of differentia-
tion with a library of kinase inhibitors (Supplementary Table 1)
followed by isoproterenol stimulation, and measured Ucp1
mRNA expression 6 h later. Apart from two pan-kinase inhibitors
included in the screen, SYK inhibitor ER27319 (SYK-i1)11 was
the only compound tested that resulted in almost complete loss of
isoproterenol-induced Ucp1 expression (Fig. 1a). Although
known mainly for their critical roles in hematopoietic cells, SYK
as well as several SYK interaction partners and targets including
tyrosine-protein phosphatase non-receptor type 6 (SHP1), Bru-
ton’s tyrosine kinase (BTK) and 1-phosphatidylinositol 4,5-
bisphosphate phosphodiesterase gamma-2 (PLCγ2) were indeed
induced during in vitro brown fat differentiation (Fig. 1b, Sup-
plementary Fig. 5) and detected in whole mature BAT, albeit
expression as a fraction of total protein was much lower than in B
cells (Fig. 1c, Supplementary Fig. 5). SYK activity is controlled by
phosphorylation9. Although we were unable to detect phos-
phorylated SYK by western blotting, we detected an increase of
phosphorylated SYK following isoproterenol treatment using
immunoﬂuorescence (IF) that was blocked when the cells were
pretreated with SYK inhibitor R406 (SYK-i3)12 (Fig. 1d, Supple-
mentary Fig. 1a) (n = 5). Similarly, no phosphorylated SYK
immunoﬂuorescence signal was detected when mature day 8
adipocytes deleted for SYK (Fig. 2a) were stimulated with iso-
proterenol (Supplementary Fig. 1a) (n = 3). This indicates that
isoproterenol enhances SYK activity by triggering its
phosphorylation.
SYK inhibits β-agonist-induced Ucp1 expression and O2 con-
sumption. To conﬁrm the identiﬁcation of SYK in adipocytes as
essential for isoproterenol-induced Ucp1 expression in vitro, we
used multiple approaches ranging from siRNA knock down, 4
different SYK inhibitors, and Cre-mediated deletion of Syk. We
blocked SYK activity using two inhibitors and depleted Syk RNA
by ~90% using two different siRNAs (Supplementary Fig. 1b) in
immortalized day 8 differentiated brown adipocytes13 (Fig. 1e).
Furthermore, we tested SYK-i3 on primary day 8 differentiated
brown adipocytes (Fig. 1f), and cells derived from CreERT2
Sykﬂox/ﬂox (KO) mice or Sykﬂox/ﬂox (WT) control mice in which
genetic Syk deletion was induced in vitro by adding 4-hydroxy
tamoxifen (4-OHT) with up to 90% deletion in mature brown
adipocytes (Fig. 1f and Fig. 2a). In all cases, isoproterenol-induced
Ucp1 RNA expression was reduced (Fig. 1e–f). Basal levels of
Ucp1 expression in unstimulated cells, whether treated with
inhibitors, siRNAs, or in Syk KO cells, were not affected by SYK
modulation (Supplementary Fig. 1c–d). Cells pretreated with
SYK-i1 at day 8 of differentiation followed by stimulation with
isoproterenol for 48 h also failed to induce UCP1 expression at
the protein level (Supplementary Fig. 1e, Supplementary Fig. 5).
Conversely, overexpression of SYK (Syk-OE) or phosphatase
inhibition (Phos-i), which augments SYK activity14, 15, enhanced
Ucp1 expression in isoproterenol treated adipocytes (Fig. 1g,
Supplementary Fig. 1f–h, Supplementary Fig. 5), while basal levels
of Ucp1 were not affected (Supplementary Fig. 1h). Consistent
with the results of isoproterenol stimulation, forskolin, a direct
activator of cAMP synthesis, induced Ucp1 upregulation in WT
but not KO cells (Supplementary Fig. 1i).
Further, isoproterenol-mediated acute oxygen consumption in
mature brown adipocytes was impaired by pretreatment with the
SYK inhibitor Bay61-3606 (SYK-i2)16 (Fig. 1h, left panel). Knock
down of Syk starting at day 6 of differentiation already lowered
the basal oxygen consumption at day 10 of differentiation and
treated cells were also impaired in isoproterenol-mediated acute
induction of oxygen consumption (Fig. 1h, right panel). Finally,
we showed that SYK is important for isoproterenol-induced
lipolysis. Glycerol released to the media by brown adipocytes was
decreased when the cells were pretreated with SYK-i1 or SYK-i2
(Fig. 1i). Similarly, glycerol release in white adipocytes was also
reduced in the presence of SYK inhibitors (Supplementary
Fig. 1j).
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Thus, SYK is expressed in brown fat cells, is developmentally
upregulated, and critically mediates the upregulation of Ucp1,
oxidative metabolism, and lipolysis in response to β-adrenergic
stimulation of brown adipocytes.
SYK mediates global changes in β-agonist-induced gene
expression. To test whether SYK is required for global changes in
gene expression in response to β-adrenergic stimulation of brown
adipocytes7, we used cells derived from CreERT2 Sykﬂox/ﬂox (KO)
or control Sykﬂox/ﬂox (WT) control mice and treated them with
4-OHT one day prior to the induction of differentiation; we
achieved a 90% reduction in SYK protein at day 8 of differ-
entiation (Fig. 2a, Supplementary Fig. 6). Mature adipocytes were
then stimulated with isoproterenol for 6 h and RNA-seq was
performed. Unstimulated WT and KO cells were viable, mor-
phologically normal, and displayed largely normal patterns of
gene expression as indicated by RNA-seq and qPCR analysis
(Supplementary Fig. 2a–b). As seen in Fig. 2b we identiﬁed 4372
genes that were at least 1.5-fold up or downregulated with an
FDR < 0.05 (gray dots) in response to β-adrenergic stimulation in
either the mature WT or KO adipocytes, with most genes
b
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Fig. 1 Identiﬁcation of kinases regulating Ucp1 expression in response to β-adrenergic stimulation. a Screening of a kinase inhibitor library (n= 90) to
identify small molecules modulating Ucp1 RNA expression in response to stimulation with isoproterenol in in vitro differentiated day 8 immortalized brown
adipocytes. Blue, pan-kinase inhibitors; red, SYK inhibitor ER27319; dotted line denotes + isoproterenol control (n= 3). b Representative immunoblots of
two independent in vitro differentiations of primary brown adipocytes (b) and of two independent BAT isolations with two mice each (c) of SYK and
pathway members as well as brown adipocyte markers. d Immunoﬂuorescence of primary brown adipocytes stimulated with isoproterenol in the absence
or presence of 2 µM SYK-i3 (R406), one representative IF of ﬁve independent replicates is shown. Scale bar= 10 µm. e Ucp1 RNA expression after
stimulation with isoproterenol of differentiated day 8 immortalized brown adipocytes pretreated with 10 μM SYK inhibitors (SYK-i1 is ER27319; SYK-i2 is
Bay 61-3606) or following transfection with siRNA targeting Syk mRNA 4 days prior (si1-Syk and si2-Syk) (n= 3). f Isoproterenol-induced Ucp1 RNA
expression in primary day 8 brown adipocytes in vitro pretreated with SYK-i3 (R406) or in primary day 8 brown adipocytes derived from CreERT2 Sykﬂox/
ﬂox mice (KO) or Sykﬂox/ﬂox (WT) both treated with 4-hydroxy tamoxifen (4-OHT) one day prior to induction of differentiation (n= 3). g Ucp1 RNA
expression in primary day 8 brown adipocytes after overexpression of wild-type mouse SYK (Syk-OE1 and Syk-OE2) or pretreatment with 1 μM
phosphatase inhibitor 3AC and stimulation with isoproterenol (n= 2). h Oxygen consumption rate (OCR) of immortalized brown adipocytes stimulated
with isoproterenol and pretreated with 10 μM (SYK-i2) or following siRNA mediated knock down of Syk 4 days prior to measurement (si1-Syk, si2-Syk).
Results are shown as average OCR + SEM of 18 measurements per time point and representative of three replicates. i Cell culture medium glycerol content
from immortalized brown adipocytes at day 8 treated with isoproterenol in the absence or presence of 10 µM SYK-i2 (n= 3). For a, e–g, mean % of iso
stimulated control± SEM. For e, g, i, two-tailed unpaired Student’s t test was performed (*P< 0.05, **P< 0.005 and ***P< 0.0005). For f, two-tailed
unpaired Student’s t test was performed on Log transformed values
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showing a similar pattern of up- or down-regulation. To identify
the genes affected by SYK deletion, we looked for genes that
showed a differential fold change >1.5 with a p value< 0.05 upon
β-adrenergic stimulation in WT compared to SYK-deleted cells
(Methods section). We identiﬁed 307 genes, several of which were
enriched in pathways involved in brown fat cell differentiation, fat
cell differentiation, oxidation-reduction, and others (Fig. 2c,
Supplementary Fig. 2c–d). We validated the expression of several
genes by qPCR and included others that are important in brown
fat cell differentiation and mitochondrial biogenesis. Indeed, Syk
KO adipocytes, compared to WT adipocytes, showed impaired
induction or suppression of many genes characteristic of or
required for brown adipogenesis (Ucp1, Dio2, Prdm16, Pparα,
and Cidea) and mitochondrial biogenesis and function following
treatment with isoproterenol (Nrf1, Tfam, Pgc-1α, Cox4i, Cox7a1,
and Ndufs3) (Fig. 2d). Stimulation of brown adipocytes that were
pretreated with SYK-i3 and subsequently stimulated with iso-
proterenol for 6 or 48 h similarly resulted in impaired induction
and expression of genes encoding proteins enriched in brown fat,
mitochondria, and adipogenesis at both mRNA (Supplementary
Fig. 2e) and protein levels (Fig. 2e, Supplementary Fig. 6),
whereas expression of other genes such as those encoding β-actin
or an ATP synthase subunit (ATP5a) were normal (Fig. 2e).
To identify downstream targets of SYK, we reanalyzed the screen
of kinase inhibitors used in theUcp1 expression screen (Fig. 1a) and
identiﬁed as the next top hits inhibitors of the PI3K, mTOR, AKT,
and PKA pathways (Supplementary Fig. 2f). Indeed, inhibition of
members of the mTOR, AKT, and PKA pathways, suppressed
isoproterenol-induced Ucp1 expression in both primary and
immortalized day 8 differentiated brown adipocytes (Fig. 2f).
Inhibition of PI3K using inhibitor PI828 showed 50% inhibition of
Ucp1 expression only at a very-high dose (>25 µM), hence, we are
uncertain of the speciﬁcity of the used inhibitor. Pretreatment with
SYK-i3 reduced isoproterenol-induced phosphorylation of mTOR
complex1 (mTORC1) and mTORC2 substrate phosphorylation
target S6K, AKT phosphorylation, and PKA substrate phosphoryla-
tion in both primary brown adipocytes (Fig. 2g, Supplementary
Fig. 6) and immortalized mature brown adipocytes (Supplementary
b
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Fig. 2 SYK mediates expression of characteristic brown fat genes and activates the AKT/mTOR pathway. a Representative immunoblots of SYK protein
expression from three independent differentiations of in vitro differentiated brown adipocytes from CreERT2 Sykﬂox/ﬂox mice on day 8 of differentiation
following continuous treatment with 4-hydroxy tamoxifen (4-OHT) for 9 days. b RNA-seq was conducted on 3 replicates of 4-OHT treated Sykﬂox/ﬂox
(WT) and CreERT2 Sykﬂox/ﬂox (KO) cells as shown in a before and after isoproterenol treatment at day 8 of differentiation. Log fold change in WT cells
before and after induction is shown on the x axis and log fold change in KO cells before and after induction is shown on the y axis. Genes shown had at least
a 1.5-fold up- or down-regulation in WT or KO cells after stimulation with an FDR< 0.05. Genes with a fold change difference of 1.5 higher in WT
compared to KO with a p value< 0.05 are shown in red. c Enriched GO categories with a Benjamini adjusted p value< 0.05 for genes shown in red in b. d
Fold change of mRNA expression in day 8 differentiated primary brown adipocytes with tamoxifen-induced reduction in SYK protein as described in (a) and
stimulated with isoproterenol. e Representative immunoblots of two independent experiments of primary brown adipocytes stimulated with isoproterenol
on day 8 of differentiation for 48 h in complete medium in the presence or absence of 5 μM SYK-i3. f Day 8 differentiated brown adipocytes (prim, primary;
imm, immortalized) stimulated with isoproterenol and pretreated with mTORC inhibitors torin 1 (10 μM), torin 2 (10 μM) or KU0063794 (10 μM), AKT
inhibitor API-2 (10 μM), or PKA inhibitors PKI 14-22 (10 μM), or H89 (10 μM) (n= 3). g Representative immunoblots of three independent experiments of
day 8 primary brown adipocytes pretreated with 5 μM SYK-i3 and stimulated with isoproterenol for 5 min. pPKAsub, antibody recognizing PKA substrate
phosphorylation motif RRXS*/T*. For f, mean %± SEM and d, fold change vs unstimulated control± SEM was calculated. For d, two-tailed unpaired
Student’s t test was performed (*P< 0.05, **P< 0.005 and ***P< 0.0005) and for f, a one-way ANOVA was performed
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Figs. 2g and 6). These data show that SYK is likely upstream of these
pathways.
In summary, in in vitro cultures of brown adipocytes
stimulated by β-adrenergic agonists, SYK promotes and is
necessary for expression of numerous genes involved in brown
adipogenesis and brown adipocyte mitochondrial biogenesis; SYK
is also essential for activation of critical downstream signaling
pathways, including the mTOR, AKT and PKA pathways.
SYK is required for pre-adipocyte proliferation and differ-
entiation. Acute sympathetic stimulation of BAT leads to acute
brown adipocyte activation, and chronic stimulation induces pro-
liferation of brown adipocyte precursors, their differentiation to
brown adipocytes, and ultimately tissue growth7, 17. The mTOR and
PKA pathways critically regulate these processes in vitro and
in vivo18, and since we place SYK upstream of these pathways it
raises the possibility that SYK is also required for both brown pre-
adipocyte proliferation and brown adipocyte differentiation. To test
this hypothesis, we isolated brown and white pre-adipocytes from
CreERT2 Sykﬂox/ﬂox (KO) and control Sykﬂox/ﬂox (WT) mice and
treated both with 4-OHT. Treatment resulted in a ~80% loss of SYK
in CreERT2 Sykﬂox/ﬂox (KO) but not in Sykﬂox/ﬂox (WT) control
cells (Fig. 3a, Supplementary Fig. 7). Indeed, brown and white pre-
adipocyte proliferation required SYK, as indicated by diminished cell
numbers (Fig. 3b and Supplementary Fig. 3a). The reduced cell
numbers could not be explained by an increase of apoptosis, as
staining with Annexin V and 7-AAD did not show a signiﬁcant
increase of apoptotic or dead cells in KO cultures (Supplementary
Fig. 3b–d).We then tested cell proliferation in brown pre-adipocytes
by CFSE staining and detected delayed cell division both in Syk KO
cells (Fig. 3c) and SYK-i3-treated cells (Fig. 3d).
For proper induction of differentiation, pre-adipocytes need to
be cultured to the point where they are growth arrested. Pre-
adipocytes derived from CreERT2 Sykﬂox/ﬂox mice were delayed
in cell growth, did not reach conﬂuency, and did not differentiate
to the same extent as did cells from Sykﬂox/ﬂox control mice
(Supplementary Fig. 3e). The few brown adipocytes formed after
8 days expressed normal protein levels of SYK (Supplementary
Figs. 3f and 7), suggesting that only the few SYK proﬁcient brown
pre-adipocytes that escaped homozygous Syk deletion were able
to differentiate in these cultures. Thus, since SYK is required for
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pre-adipocyte proliferation, these experiments cannot be used to
determine whether SYK additionally is required for brown
adipocyte differentiation.
To show that SYK is necessary for brown and white adipocyte
differentiation, we added two different SYK inhibitors to
the induction media of primary wild-type brown and white
pre-adipocytes as well as to immortalized brown pre-adipocytes;
both inhibitors blocked brown and white adipocyte differentia-
tion without impairing viability (Fig. 3e, g, Supplementary
Fig. 3g). In addition, these inhibitors caused reduced expression
of genes critical for brown and white fat differentiation and
mitochondrial function at day 4 of differentiation (Fig.3f, h,
Supplementary Fig. 3h). In summary, SYK is essential for both
brown and white pre-adipocyte proliferation and for brown and
white adipocyte differentiation in vitro, consistent with a role for
SYK signaling in mTOR and PKA activation and expression of
genes involved in adipogenesis as well as mitochondrial
biogenesis and function. Determining how SYK becomes
activated in both pre-adipocytes and adipocytes, and how SYK
activates multiple downstream signaling pathways remain to be
deciphered.
SYK is important for generation of brown adipocytes in vivo.
To determine whether SYK is also required for brown adipocyte
differentiation in vivo, we generated mice with a fat-speciﬁc
deletion of the Syk gene by combining an adiponectin promoter
driven Cre recombinase allele (AdipoQCre) with a Syk allele
harboring loxP sites ﬂanking exon 119, 20. When housed at 20 °C,
only 77% AdipoQCre Sykﬂox/ﬂox mice were alive at weaning age
compared to Sykﬂox/ﬂox control mice (Fig. 4a); this may account
for part of the postnatal mortality observed in mice with a
germline deletion of Syk21, 22. This phenotype was not observed
when the mice were housed at 30 °C (Fig. 4a), suggesting a brown
fat defect in AdipoQCre Sykﬂox/ﬂox mice.
Consistent with impaired brown adipocyte precursor expan-
sion in vitro (Fig. 3a–d), BAT depot mass was decreased in four
week old AdipoQCre Sykﬂox/ﬂox mice compared to Sykﬂox/ﬂox
control mice (Fig. 4b). The remaining BAT of AdipoQCre
Sykﬂox/ﬂox mice expressed normal levels of SYK protein and was
otherwise similar to controls, as judged by immunoblotting and
qPCR of BAT enriched genes, mitochondrial genes, adipogenic
genes and genes involved in lipid metabolism (Fig. 4d,
Supplementary Figs. 4a and 8). The subcutaneous inguinal white
adipose tissue (scWAT) of AdipoQCre Sykﬂox/ﬂox mice displayed
increased expression of BAT enriched genes, compared to
scWAT from Sykﬂox/ﬂox control mice, as well as histological
features of browning and UCP1 expression. (Fig. 4c, Supplemen-
tary Figs. 4b–d and 9). This suggested compensatory beige
adipocyte formation from the remaining progenitor cells that
escaped homozygous Syk deletion, reminiscent of other mouse
models with decreased BAT mass23. Similarly, we generated mice
with a Ucp1Cre driven brown fat-speciﬁc deletion24 and bearing
a Syk allele harboring loxP sites (Ucp1Cre Sykﬂox/ﬂox). The BAT
in these mice also expressed normal levels of SYK protein
(Supplementary Figs. 4e and 9). Fat-speciﬁc SYK deletion both in
culture and in vivo thus results in decreased BAT mass, favoring
the proliferation and differentiation of residual SYK-expressing
brown adipocytes.
As expected from the reduced amount of apparently normal
BAT that escaped Syk deletion, AdipoQCre Sykﬂox/ﬂox mice, on a
high fat diet (HFD) gained more weight and became more
glucose intolerant than Sykﬂox/ﬂox control mice. They also
displayed insulin resistance on a chow diet (Fig. 4e–f, Supple-
mentary Fig. 4f–g). RNA expression of genes regulating lipolysis
and lipogenesis in scWAT, visWAT and BAT of these mice was
similar to controls, suggesting that obesity in these mice may not
be due to a lipolysis or lipogenesis defect (Supplementary Fig. 4h).
To conﬁrm the deletion of the Syk gene in BAT of AdipoQCre
Sykﬂox/ﬂox mice, we isolated pre-adipocytes from BAT depots of
AdipoQCre Sykﬂox/ﬂox and Sykﬂox/ﬂox control mice as well from
heterozygous Syk+/ﬂox and AdipoQCre Syk+/ﬂox mice and
induced them to differentiate in vitro. We were able to detect
faint amounts of the deleted allele at day 0, before induction of
differentiation in progenitors from the AdipoQCre Sykﬂox/ﬂox and
AdipoQCre Syk+/ﬂox mice but not the control mice, indicating a
low level of expression of the AdipoQCre transgene and Cre
activity in the progenitors (Fig. 4g, Supplementary Fig. 8). During
differentiation of these AdipoQCre expressing progenitor cells in
culture the intensity of the deleted allele “band” increased,
correlating with induction of AdipoQCre expression during BAT
differentiation (Fig. 4g). Thus the absence of deleted Syk in
mature BAT cells from AdipoQCre Sykﬂox/ﬂox mice is not due to
faulty Cre recombinase activity, but rather to poor differentiation
of Syk-deleted BAT progenitors. By quantifying the extent of the
deletion by Southern blotting we found a ~50 % deletion of the
loxP-ﬂanked Syk allele in BAT of AdipoQCre Sykﬂox/ﬂox as well as
in Ucp1Cre Sykﬂox/ﬂox mice, compared to heterozygous germline
deleted BAT (Fig. 4h, Supplementary Figs. 4i, 8 and 9). This again
suggested selection for brown adipocytes with a heterozygous (or
no) Syk deletion and against those with complete Syk deletion.
We also detected the deleted allele in scWAT and visWAT of
AdipoQCre Sykﬂox/ﬂox mice (Supplementary Figs. 4j and 9).
Consistent with a requirement for SYK in brown pre-adipocyte
proliferation (Fig. 3a–d), these results suggest that Cre-mediated
deletion of SYK beginning in proliferating brown adipocyte
precursors selects for the development of fewer but otherwise
normal SYK-expressing brown adipocytes that have escaped
homozygous deletion of the loxP-ﬂanked Syk allele. Thus, SYK
deﬁciency is incompatible with brown adipocyte development,
indicating that SYK is essential for brown fat formation in vivo.
SYK inhibition impairs thermogenesis in vivo. To address
whether SYK function is important in established brown fat, we
injected mice with a highly selective SYK inhibitor PRT062607,
one that is longer-lasting in vivo than the SYK inhibitors we used
in our cell culture experiments. We measured oxygen consump-
tion before and after stimulation of β-adrenergic signaling in
brown fat by the β3-agonist CL 316,24325. Mice injected with the
vehicle and subsequent injection of CL 316,243 increased oxygen
consumption whereas mice preinjected with SYK inhibitor
PRT062607 failed to induce CL 316,243-dependent oxygen con-
sumption (Fig. 4i, upper panel) in the absence of any signiﬁcant
changes in physical movements (Fig. 4i, lower panel). Moreover,
mice injected with PRT062607, but not controls, underwent
hypothermia upon cold exposure (Fig. 4j). We then deleted SYK
in established BAT using CreERT2 Sykﬂox/ﬂox mice or Sykﬂox/ﬂox
control mice by injecting tamoxifen intraperitoneally (i.p.) for
5 days, which resulted in an almost complete loss of SYK protein
16 days post tamoxifen injection (Fig. 4k, Supplementary Fig. 8).
This SYK deﬁcient BAT was grossly normal morphologically and
displayed normal expression of UCP1 and other mitochondrial
and adipogenesis enriched genes, as well as of PKA, S6K, and
AKT (Fig. 4k, Supplementary Figs. 4k, 8 and 9). SYK is thus not
required for survival of established BAT or maintenance of
expression of brown fat characteristic genes. However, as
judged by measuring the oxygen consumption of these mice in
metabolic chambers, CreERT2 Sykﬂox/ﬂox mice failed to induce
CL 316,243-induced oxygen consumption, as contrasted with
control Sykﬂox/ﬂox mice (Fig. 4l). SYK signaling thus promotes
β-adrenergic induced BAT activation in vivo.
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Discussion
This study revealed an unexpected and crucial role for the
immune kinase SYK in brown adipocyte differentiation, activa-
tion, and function. In mature brown adipocytes in vitro and
in vivo, inhibition or deletion of SYK blocked upregulation of
Ucp1 expression and oxygen consumption in response to β-
adrenergic signaling. In hematopoietic cells, SYK activation
requires binding to phosphorylated ITAMs associated with
immunoreceptors, and subsequent phosphorylation of SYK by
LYN family protein tyrosine kinases9. Indeed we detected SYK
phosphorylation in response to β-adrenergic stimulation but the
precise molecular mechanism of SYK activation in brown
adipocytes is unknown. It may require the association with a yet
unidentiﬁed YXXL/I ITAM motif in a BAT protein. Alternatively,
a yet unknown ITAM- independent pathway could be involved.
In line with our data, other studies have also shown that β-
adrenergic stimulation of brown adipocytes induces mTOR sig-
naling measured by increased Akt Ser473 and S6K phosphor-
ylation26, 27. Although we found that SYK enhances mTOR
activation, measured as increased phosphorylation of the down-
stream effector S6K, we have been unable to identify proteins
directly phosphorylated by SYK. This is a major ongoing effort in
our lab. This determination is not straightforward as we do not
know which are direct and indirect targets of this kinase and
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denote statistical signiﬁcance (p< 0.05) determined by two-tailed t test and for c, asterisks denote statistical signiﬁcance (p< 0.05) determined by two-
tailed t test
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interactions of kinases and target proteins are usually very
transient.
Most importantly, we found that adipose- or BAT-speciﬁc
deletion of SYK, using AdipoQCre or Ucp1Cre driven inducers of
deletion in vivo, probably starting early after birth, results in
strong counter selection of SYK proﬁcient cells. This phenom-
enon has previously been observed in B cells with conditional
gene targeting of essential genes28, 29. As a result of this counter
selection, the mice display reduced BAT mass and predisposition
to weight gain and glucose intolerance. This phenotype resembles
that of other knockout models with reduced BAT mass30, 31.
SYK deletion or inhibition decreased proliferation and differ-
entiation of brown adipocyte precursors in vitro and prevented
normal BAT development. However, once brown adipocytes have
formed, SYK was dispensable in maintaining basal functions of
mature brown fat cells but was still necessary for the thermogenic
response to β-adrenergic signaling.
A better understanding of the regulation of SYK activity and its
targets in brown fat and possibly also in white fat thus has the
potential to reveal novel avenues towards the treatment of
metabolic diseases.
Methods
Mice. C57BL/6J mice were bred in house or purchased from Jackson Laboratories
(stock #000664). Sykﬂox/ﬂox mice backcrossed 8 times to C57BL/6 mice were a kind
gift of Alexander Tarakhovsky, Rockefeller University, and can be purchased from
Jackson Laboratories (stock # 017309)19. To generate mice with an inducible Syk
deletion, Sykﬂox/ﬂox mice were crossed with UBC-CreERT2 mice (Jackson
laboratories #008085, CreERT2 in the manuscript). AdipoQCre mice on a C57BL/6
background were a gift of Evan Rosen, Beth Israel Deaconess Medical Center, and
are available at Jackson Laboratories (stock #010803). Ucp1Cre mice were obtained
from Jackson laboratories (stock #024670)24. In all experiments, Sykﬂox/ﬂox mice
bearing a Cre allele were compared to sex-matched Sykﬂox/ﬂox littermate or age-
matched controls. To generate mice with a germline heterozygous Syk deletion,
Sykﬂox/ﬂox mice were bred with CMV-Cre mice (Jackson laboratories # 006054). All
mice were housed under a 12 h light/dark cycle at constant temperature (20 °C). All
procedures were performed according to protocols approved by the Committee on
Animal Care at the Massachusetts Institute of Technology.
Pre-adipocyte isolation. 6–8 2-week to 4-week-old male mice were sacriﬁced by
CO2 asphyxiation and interscapular brown adipose tissue (BAT) and subcutaneous
(inguinal) white adipose tissue (scWAT) was harvested into room temperature
plain DMEM (Sigma, #56499C). Then the fat pads were transferred into a well of a
6 well plate, excessive media removed and minced with scissors for 5 min. Minced
tissues were then transferred into a 50 ml conical tube with 3 ml Hank’s balanced
salt solution (Gibco, #14175–095) supplemented with 0.2% collagenase A (Roche,
#10103578001) and 2 % BSA (Sigma-Aldrich, #A7906) using a 1 ml pipet tip with
the tip cut off to allow aspiration of larger pieces. The tissues were incubated
agitating (350 rpm) and repeated vortexing every 5 min for 10 s at 37 °C for 30 min.
Following collagenase digestion, 10 ml room temperature plain DMEM was added
and cells were ﬁltered through a 70 µm mesh ﬁlter (Corning, #352350). Mature
adipocytes and the stromal vascular fraction (SVF) were separated by centrifuga-
tion at 700 g for 5 min. The supernatant was removed and the SVF resuspended in
10 ml room temperature plain DMEM followed by additional ﬁltering through a
30 µm mesh ﬁlter (Miltenyi Biotec #130-041-407) and subsequent centrifugation at
700 g for 5 min. The SVF from subcutaneous white fat pads (scWAT) of 8 mice
were then resuspended in 10 ml proliferation media Advanced DMEM/F12
(DMEM/F12, LifeTechnologies/Gibco #12634028) supplemented with 5% heat
inactivated newborn calf serum (HI NCBS, LifeTechnologies/Gibco, #26010-074),
5% fetal calf serum (FBS, Sigma-Aldrich F2442), 100 units penicillin, 100 µg
streptomycin (Pen/Strep, LifeTechnologies/Gibco, #15140-122, 100×), 1× Gluta-
max (LQX, LifeTechnologies/Gibco, #35050-061) and plated on two 10 cm dishes
(Corning, #430293) in a total volume of 10 ml per 10 cm plate. The SVF from
interscapular brown fat pads of 6–8 mice were then resuspended in 6 ml DMEM/
F12 supplemented with 5% HI NCBS, 5% FBS, Pen/Strep and LQX as above and
plated on 3 wells of a six well plate (Corning, #3506) in a total volume of 2 ml per
well. After 4 and 24 h, the medium was replaced by fresh, pre-warmed DMEM/
F12/5% HI NBCS, 5% FBS, Pen/Strep and LQX at 37 °C and with 5% CO2. Cells
were grown to conﬂuency and then passaged no more than two times before
seeding the pre-adipocytes for differentiation.
Pre-adipocyte differentiation. Pre-adipocytes derived from BAT were seeded in
experimental plates at a density of 5 × 105 per six well plate after the second passage
and cultured in proliferation media as described above to conﬂuence for 4 days
when the cells were growth arrested. The cells were then induced to differentiate by
culturing them for two days in induction medium consisting of DMEM supple-
mented with 10% fetal bovine serum and 850 nM insulin (Sigma-Aldrich #I1882),
0.5 µM dexamethasone (Sigma-Aldrich #D4902), 250 µM 3-isobutyl-1-
methylxanthine (IBMX, Sigma-Aldrich #I5879), 1 µM rosiglitazone (Cayman
Chemical #71742), 1 nM 3,3,5-triiodo-L-thyronine (T3, VWR #100567-778) and
125 nM indomethacin (Sigma-Aldrich #I7378). Subsequently, after two days the
induction medium was replaced with DMEM supplemented with 10% FBS and
160 nM insulin and 1 nM T3 for another 2 days. The cells were then cultured in
DMEM 10% FBS and 1 nM T3 until day 8 of differentiation, and the medium was
replaced every other day. Pre-adipocytes derived from WAT were seeded, grown
and differentiated in the same way as pre-adipocytes derived from BAT but no T3
or indomethacin was added to the induction media.
Differentiation of immortalized brown adipocyte precursors. The immortalized
brown pre-adipocyte cell line (WT-1) was previously established by transformation
of brown pre-adipocytes from wild-type newborn mice with SV40 large T antigen
and kindly provided by Dr. C. Ronald Kahn10. These mycoplasma free cells were
propagated in DMEM containing 10% FBS, 62.5 μg/ml penicillin and 100 μg/ml
streptomycin (all from Life Technologies). Two days post conﬂuence (designated
day 0) differentiation was induced by addition of propagation medium supple-
mented with 1 μM dexamethasone (Sigma-Aldrich), 0.5 mM IBMX (Sigma-
Aldrich), 5 μg/ml insulin (Roche) and 0.5 μM rosiglitazone (Cayman Chemical).
On day 2, the medium was replaced with medium containing 5 μg/ml insulin and
0.5 μM Rosiglitazone. Beginning day 4, the cells were cultured in propagation
medium until analysis on day 8 or day 10 of differentiation.
Adipocyte stimulation with isoproterenol. Mature adipocyte cell layers were
washed twice in plain pre-warmed DMEM and cultured in plain DMEM with
inhibitors prior to stimulation with the following isoproterenol (Sigma-Aldrich
I6504) concentrations: 0.1 μM immortalized day 8 and day 10 brown adipocytes; 1
and 0.1 μM d8 brown adipocytes. After 6 h of treatment, the cells were washed once
with cold PBS and RNA was harvested using TRizol or QIAzol lysis reagent as
described below. For immunoblotting, the cultures were harvested after indicated
treatment times with isoproterenol after washing with cold PBS on ice and adding
50 μl RIPA buffer per well of a 6 well plate or 100 μl RIPA buffer to a 10 cm dish.
For stimulation with forskolin (Sigma-Aldrich F3917) 1μM dissolved in DMSO
was used.
Chemical inhibitors. All inhibitors were added to adipocyte cultures after addition
of plain DMEM and 30min (primary cultures) to 1 h (immortalized cultures) prior
to addition of isoproterenol. SYK-i1/ER27319 (Tocris Bioscience), SYK-i2/BAY61-
3606 (Sigma-Aldrich), SYK-i3/R406 (free base, Selleck Chemicals #S1533), SYK-i4/
PRT062607 (Selleck Chemicals #S8032) and SHP1 inhibitor 3AC (EMD Millipore
#5658351) were reconstituted in DMSO and stored at −80 °C. mTOR inhibitors
(Torin 1, torin 2, KU0063794), Akt inhibitor API-2, PKA inhibitor PKI 14-22 were
all obtained from Tocris Bioscience, PKA inhibitor H89 was purchased from Santa
Cruz Biotechnology were all reconstituted in DMSO, stored at −80 °C and used at a
ﬁnal concentration of 10 µM.
Kinase inhibitor screen. Different kinase inhibitors (n = 90) were added directly to
the cell culture well 1 h before stimulation with 0.1 μM isoproterenol for 6 h. The
experiment was performed in 12-well plates and each plate contained 10 wells
stimulated with isoproterenol and pretreated with 10 μM kinase inhibitor and two
control wells, one unstimulated and one isoproterenol stimulated well. Relative
Ucp1 RNA expression was normalized to the plate speciﬁc isoproterenol stimulated
control for each individual experiment. An overview of kinase inhibitors included
in the screen is provided in Supplementary Table 1.
Induction of Cre recombinase by 4-hydroxy tamoxifen (4-OHT) in culture. To
generate mature, day 8 differentiated Syk KO cells, brown pre-adipocytes were
isolated from CreERT2 Sykﬂox/ﬂox male mice or littermate Sykﬂox/ﬂox control male
mice, grown to conﬂuency in proliferation media and 1 μM 4-hydroxy tamoxifen
(4-OHT, Sigma-Aldrich #7904; reconstituted in ethanol) was added 1 day prior to
induction of differentiation (d-1). The next day, cells were induced to differentiate
(d0) as described above in the presence of 1 μM 4-OHT and complete medium
change every other day with fresh 1 μM 4-OHT for 8 days. These in vitro differ-
entiated day 8 brown adipocytes derived from CreERT2 Sykﬂox/ﬂox mice or Sykﬂox/
ﬂox control mice were washed twice in plain DMEM and starved for one hour prior
to stimulation with 0.1 μM isoproterenol or 1 μM forskolin.
To delete Syk in brown pre-adipocytes, again, cells were isolated from CreERT2
Sykﬂox/ﬂox male mice or littermate Sykﬂox/ﬂox control male mice cultivated in
proliferation media for 3 days, passaged the ﬁrst time and seeded with the same cell
number in the presence of 1 μM 4-OHT. After another 3 days, cells were passaged
again and seeded with the same cell numbers counting as day 0 in Fig. 3b although
there was no statistical difference in cell numbers at that point. A representative
plate was harvested and counted after 5 and 8 days in culture as shown in Fig. 3b or
for western at indicated timepoints as seen in Supplementary Fig. 3f 1 μM 4-OHT
was added freshly every other day with a complete medium change. After the last
counting at day 8, cells were induced to differentiate as described above.
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Apoptosis assay. Brown or white pre-adipocytes from CreERT2 Sykﬂox/ﬂox male
mice or littermate Sykﬂox/ﬂox control male mice were treated as described above.
After counting, 2 × 105 cells were used to stain with Annexin V and 7-AAD using
the Violet Annexin V/Dead Cell Apoptosis Kit (Life Technologies, A35136) fol-
lowing the instructions of the manufacturer. Brieﬂy, 2 × 105 cells were resuspended
in 200 μl Annexin V binding buffer and 5 μl of Paciﬁc Blue annexin V and 1 μl of
SYTOX AADvanced Dead Cell Stain (500 μM) were added. The cells were incu-
bated at room temperature for 30 min, washed twice in Annexin V binding buffer
and analyzed using an LSR II ﬂow cytometer.
CFSE staining. Brown pre-adipocytes from CreERT2 Sykﬂox/ﬂox male mice or
littermate Sykﬂox/ﬂox control male mice were treated as described above. After
4 days in the presence of 1 μM 4-OHT, cells were washed twice in pre-warmed
plain DMEM media and incubated with 1 ml DMEM supplemented with 1 μl
CellTrace stock solution (5 mM) at 37 °C for 20 min. Cells were then washed twice
in DMEM with 10% FBS to remove residual free dye and incubated with DMEM in
the presence of 10% FBS and 1 μM 4-OHT. Cells were harvested every day for
5 days and CFSE dilution was measured using a LSRII ﬂow cytometer. Wild-type
brown pre-adipocytes were stained similar but after the initial staining (day 0) cells
were incubated in the presence of SYK-i3 (R406) and measured every day for
5 days.
Syk overexpression. Brown pre-adipocytes were transduced with either of two
retroviral vectors expressing wild-type mouse Syk tagged with mCherry32 one day
prior to differentiation (d-1) for use on day 8 of differentiation.
siRNA transfection. Was performed as described in Isidor et al.13. Brieﬂy, on day
6 of differentiation, immortalized brown pre-adipocytes were transfected with 5
nM siRNA (Sigma-Aldrich) using 5 μl/ml Lipofectamine RNAiMAX diluted in
Opti-MEM I Reduced Serum Medium (Life Technologies). The cultures were
analyzed on day 10 of differentiation.
In vitro oxygen consumption rate. Measurement of cellular oxygen consumption
rate (OCR) was performed using the Seahorse XF96 Extracellular Flux Analyzer
(Seahorse Bioscience). One hour before measurement, the cell culture medium was
replaced with DMEM (Sigma-Aldrich) and 5 mM glucose adjusted to pH 7.4. Basal
OCR was measured before the successive addition of 10 μM SYK-i2/BAY 61-3606,
1 μM isoproterenol (for inhibitor experiments) or the addition of 1 μM iso-
proterenol (for knock down experiments). Results are shown as average OCR +
SEM of 18 measurements per time point and representative of three independent
experiments.
Glycerol release. Following addition of fresh medium, cells were pretreated with
SYK inhibitor and stimulated with ISO. Cell culture medium was collected after 6 h
(brown) or 24 h (white) of stimulation and stored at −20 °C. Glycerol release was
measured using the Adipolysis Assay Kit (Cayman Chemical, 10009381) following
the instructions of the manufacturer.
High fat diet feeding. Male mice derived from multiple litters and born within one
week were separated 21 days after birth into groups of two mice per cage and a
small piece of the ear was removed from the left or right side to identify the mice
and the tissue was used for genotyping. After one week of acclimatization, high fat
diet (Research Diets Inc. #D12331) feeding started and the food was replaced
weekly. Body weight was measured once per week with the investigators blinded to
the genotype of the mice. Control cohorts were maintained on a chow diet (Lab-
diet, 5P00 Prolab RMH 3000). F tests to compare variances were used to determine
that the weight distribution of the AdipoQCre Sykﬂox/ﬂox mice was signiﬁcantly
greater than in Sykﬂox/ﬂox controls.
Glucose and insulin tolerance tests. For glucose tolerance test, mice were fasted
for 12 h and injected intraperitoneally with 1 g/kg body weight glucose in sterile
ﬁltered 0.9% NaCl solution. For insulin tolerance tests, random fed mice were
injected intraperitoneally with 0.75U/body weight pharmaceutical grade insulin
(Humulin R, Lilly #0002-8215-01 (HI-210)). Blood glucose from the tail vein blood
was measured using Contour blood glucose meter and strips (Bayer), again with
the investigator blinded to the genotype of the mice. F tests to compare variances
were used to determine that glucose concentrations after 120 and 150 min were
signiﬁcantly greater in AdipoQCre Sykﬂox/ﬂox mice than in Sykﬂox/ﬂox control mice
in glucose tolerance tests.
Energy expenditure. Oxygen consumption (VO2) and carbon dioxide production
(VCO2) were measured by indirect gas calorimetry every 30 min or every 3 min for
acute measurements using the metabolic chamber system from TSE Systems
GmbH equipped with an optical beam activity monitoring device to measure
movement of the mice. Age-matched and gender-matched mice were placed
individually into sealed chambers supplied with chow diet and water under a 12 h
light/12 h dark cycle at 20 °C housing temperature.
Cold exposure. Mice on a chow diet and housed at 20 °C were transferred to a cold
environment (4 °C) in cages with 3–5 animals without food restriction (20 °C). The
rectal core body temperature was measured using a microprobe thermometer from
Physitemp (Model BAT-12).
Genotyping. Tail, BAT, WAT and cultured adipocyte DNA was isolated using the
DNeasy Kit (Qiagen), ampliﬁed using Platinum PCR mastermix reagents (Life-
Technologies) and separated by a 1.5% agarose gel.
The primer pairs and PCR product sizes are given in Supplementary Table 2.
Southern blotting. 10 µg genomic BAT DNA were digested with 200 U BamHI
(#R0136M, NEB) for 16 h at 37 °C and separated with a 0.7% agarose gel for 24 h at
80 V at 4 °C. Following acid-base hydrolysis, the DNA was transferred to charged
nylon membranes (HYBOND-XL, #45001151, Fisher Scientiﬁc) for 12 h. 100 ng
DNA probe (mouse Syk probe C17, same as in Saijo et al.19) were labeled with 50
μCi dCTP-α−32P (BLU013H, Perkin Elmer) using a Prime-It II Random Primer
Labeling Kit (#300385, Agilent). The labeled probe was puriﬁed with CHROMA
SPIN + STE-30 Columns (#636058, Clontech) and hybridized with the membranes
for 12 h at 60 °C. After washing, the membranes were exposed to autoradiography
ﬁlm (Biomax MS, #IB-8294985, VWR) for 24 h at −80 °C in the presence of an
intensifying screen (#IB8518706, VWR).
Quantitative PCR. Total RNA was isolated from tissues or cells using TRizol or
QIazol reagent (LifeTechnologies/Ambion) and a miRNAeasy kit (Qiagen). 300 ng
were reverse transcribed using Superscript II reverse transcriptase (Life-
Technologies/Invitrogen) using random hexamers (LifeTechnologies/Invitrogen).
The cDNA was diluted 1:10 and 2.5 µl for a 96-well plate or 1 µl for a 384 well plate
were used for quantitative Real-time PCR. qPCR was carried out on an ABI7900HT
Fast real-time PCR system (Applied Biosystems) and analyzed using the delta delta
Ct method normalized to 18S. For RNA analysis of immortalized brown adipocytes
a slightly different protocol was used: Total RNA was puriﬁed using TRI Reagent
(Sigma-Aldrich). One μg of RNA was treated with RQ1 DNase (Promega) and
reverse transcribed using Moloney murine leukemia virus reverse transcriptase
(Life Technologies) using random hexamers (Bioline). cDNA was diluted 3 times in
water. Diluted cDNA was analyzed by RT-qPCR using the Stratagene Mx3000P
QPCR system. Each PCR mixture contained 1.5 μl cDNA, 10 ul SensiFast SYBR
Lo-ROX kit (Bioline) and 2 pmol of each primer. The PCR was carried out in 96-
well plates and results analyzed using the delta delta Ct method normalized to Tbp
or 18S rRNA expression. Results are shown as pooled data from 3 to 4 independent
experiments displaying the average and SEM. Primer sequences are listed in
Supplementary Table 3.
mRNA sequencing analysis. Poly A+ RNA sequencing (TrueSeqStrandedPolyA)
was performed on RNA samples from in vitro 4-hydroxy tamoxifen (4-OHT)
treated day 8 brown adipocytes derived from CreERT2 Sykﬂox/ﬂox and Sykﬂox/ﬂox
mice 6 h following stimulation with 0.1 mM isoproterenol in serum free medium
and from unstimulated controls using a HiSeq genome sequencer (Illumina). RNA-
Seq paired-end reads from Illumina 1.5 encoding were aligned using TopHat (v
2.0.13)33 to the mouse genome (mm9; NCBI Build 37) with Ensembl annotation
(release 67) in gtf format. mRNA sequencing was performed on three independent
experiments. Differential analysis and counts per millions (cpm) were obtained by
using HTSeq Count (intersection-strict mode) and edgeR34. Since the three
replicates were done at different timepoints, we accounted for batch effects in the
design matrix and model for the comparison in edgeR. Differential fold change
used for identifying targets of Syk deletion were calculated as follows. First, we used
edgeR to calculate fold change before and after stimulation in both Sykﬂox/ﬂox
controls (referred to as FC (WT)) and CreERT2 Sykﬂox/ﬂox (referred to as FC
(KO)). We then identiﬁed genes with a difference in fold change i.e FC (WT)/
FC (KO)> 1.5 at p value< 0.05. These genes are shown in red in Fig. 2b and were
used for identifying GO categories (Fig. 2c). Enrichment analysis was performed by
GSEA35, 36 using the MSigDB (C2: curated gene sets) for genes identiﬁed in the
comparison of the fold change of stimulated and unstimulated Sykﬂox/ﬂox controls
vs. stimulated and unstimulated CreERT2 Sykﬂox/ﬂox brown adipocytes with a
partial loss of SYK protein on day 8 of differentiation. Calculated fold changes and
GSEA enrichment are listed in Supplementary Data 1.
Immunoblotting. Lysates were centrifuged for 10 min at 13,000 g and 4 °C to
remove debris, and NuPAGE sample buffer and reducing buffer (LifeTechnologies)
were added after measuring and adjusting the samples for protein concentration
(DC protein assay kit II, Bio-Rad). 2–20 μg protein per sample were separated for
2–4 h at 60–100 V using 8% 26 well NuPAGE Bis-Tris Midi gels in MOPS or MES
buffer (LifeTechnologies) and in Criterion cells (Bio-Rad) using respective adapters
(LifeTechnologies). Protein was wet transferred to polyvinylidene ﬂuoride (PVDF)
membranes (Immobilon P, Millipore) in Criterion blotter cells (Bio-Rad) using 2 x
NuPAGE Transfer buffer (LifeTechnologies) with 10 % methanol for 25 min at 1 A.
After blocking the membrane in ﬁltered (Nalgene # 595–4520) TBS-T (50 mM
Trisbase, 150 mM NaCl, 0.1% Tween 20 (Sigma-Aldrich # P1379)) with 3 % bovine
serum albumin (BSA, Sigma-Aldrich # A7906) for 1 h, blots were incubated with
primary antibody diluted in TBS-T 3% BSA sealed in hybridization bags and gently
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shaking at 4 °C overnight, then washed three times for 10 min in TBS-T, incubated
with secondary antibody (Cell Signaling Technologies) diluted in TBS-T 3% BSA
gently shaking for one hour at room temperature, and then washed again three
times for 10 min in TBS-T. Antibody binding was visualized using ECL Plus
Western Lightning reagent (Perkin Elmer NEL 102) and blots were exposed to ﬁlm
(Kodak BioMax MR Film, Carestream Health Inc # 8701302). Films were scanned
without adjustments using an Epson scanner. For immunoblotting of lysates from
immortalized brown adipocytes, a slightly different protocol was used: 30 μg pro-
tein lysate was diluted in a buffer containing 2.5% SDS and 10% glycerol and was
separated for 2.5 h using 4–12% Bis-Tris gradient gels (Life Technologies). Proteins
were transferred to Immobilon PVDF membranes (Millipore) using 1X NuPAGE
transfer buffer (Life Technologies) with 10% absolute ethanol. Membranes were
blocked in TBST-T containing 5% nonfat dry milk or BSA (Sigma-Aldrich).
Antibodies were diluted in TBST-T containing 5% nonfat dry milk or BSA and
membranes were incubated for 2 h with primary and 1 h with secondary antibody
with a washing step of 3 × 10 min before and after incubation with secondary
antibody. The membranes were developed using enhanced chemiluminescense
(ECL, Biological Industries) and the Fusion Fx (Vilber Lourmat) used for photo-
detection. All immunoblotting data shown were reproduced with almost identical
results in at least one and typically two to three additional independent experi-
ments. Experiments blotting for protein expression in ex vivo mouse tissues show
lysates derived from individual mice in each lane. For the most important western
blots, uncropped versions are provided in the Supplementary Figs. Antibody target
antigen, clone and/or order number, manufacturer and application is provided in
Supplementary Table 4.
Histology. To prepare formalin ﬁxed sections, each freshly excised tissue sample of
BAT, scWAT or visWAT was ﬁxed in 15 ml 10% neutral buffered formalin solu-
tion (Sigma-Aldrich #HT5014) gently agitating for at least 24 h. After embedding
the tissues in parafﬁn, 5 μm sections were prepared and stained with hematoxylin
and eosin following established protocols.
Oil red O staining of brown adipocyte cultures. Cells were washed in 1X PBS
and ﬁxed in 3.7% formaldehyde solution for 1 h, followed by staining with Oil Red
O for 1 h. Oil Red O was prepared by diluting a stock solution (0.5 g of Oil Red O
(Sigma) in 100 ml of isopropanol) with water (6:4) followed by ﬁltration. After
staining, plates were washed twice with water and photographed using an iPhone.
Immunoﬂuorescence. Cells isolated and grown as described above were seeded
after the second split in 8 well culture slides (BioCoat, Corning, #354631) at a
density of 1 × 105 per one well of an 8 well culture slide. Media was changed the
next day and when generating knockout cells using the pre-adipocytes from
CreERT2 Sykﬂox/ﬂox, 4-hydroxy tamoxifen (4-OHT) was added. After 24 h cells
were induced to differentiate as described above and to generate KO cells in the
presence of 4-OHT. Cells grown in 8 well culture slides were ﬁxed for 20 min in 4%
paraformaldehyde PBS solution. The cells were permeabilized with 0.25% tritonX
100 (Sigma, #T8787) for 10 min and washed 3 times with 1X PBS. Cells were then
blocked for 30 min in 1× PBS with 3% BSA following incubation with the primary
antibody (pSYK) in 1X PBS with 3% BSA for 45–60 min, washed three times with
1× PBS, and incubated with the secondary antibody, anti-rabbit F(ab)2 IgG Alexa
Fluor 488 for 45–60 min and washed three times with 1× PBS. DAPI counterstain
was performed with 100 ng/ml DAPI for 10 min and washed for three times with
1× PBS. The top of the eight-well culture slides was removed and 15 μl of ProLong
Gold antifading reagent (Invitrogen, # P36930) and a cover slip were applied.
Pictures were taken with a Zeiss LSM 700 laser scanning confocal microscope and a
20x or 63x objective using a resolution of 2048 × 2048. Lasers were calibrated to
achieve best signal to noise ration in the beginning and was not changed while
taking pictures and changing experimental conditions.
Light microscopy. A bright ﬁeld Zeiss AxioPlan2 upright microscope connected to
a CCD camera with QCapture software was used to image all tissue sections stained
with H&E and ORO.
Statistical methods. All statistical analyses were performed using Prism 7
(GraphPad Software, Inc). Statistical signiﬁcance was indicated as follows: *p <
0.05; **p< 0.005; ***p< 0.0005, and determined multiple hypothesis testing using
the Holm-Sidak method by unpaired two-tailed t test unless otherwise indicated.
The F test to compare variances was used to compare variances, and found to be
similar between groups unless indicated in the respective method sections.
Data availability. Raw data generated during the RNA-seq procedure has been
deposited in Gene Expression Omnibus (GEO) under accession code GSE91081. A
complete list (excel ﬁle) of genes modulated in WT and KO cells is provided with
the paper.
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